Patent Invalidity Claim. (a) Each of the Parties shall promptly notify the other in the event of any legal or administrative action by any Third Party against a Joint Patent Right or an AVEO Patent Right claiming Ficlatuzumab, of which it becomes aware, including any opposition, nullity, revocation, reexamination or compulsory license proceeding.
Appears in 2 contracts
Samples: Co Development and Collaboration Agreement (Biodesix Inc), Co Development and Collaboration Agreement (Aveo Pharmaceuticals Inc)
Patent Invalidity Claim. (a) Each of the Parties Party shall promptly notify the other Party in writing in the event that it becomes aware of any legal or administrative action claim asserted by any a Third Party against that a Joint Licensed Patent Right is invalid or otherwise unenforceable (an AVEO Patent Right claiming Ficlatuzumab“Invalidity Claim”), of which it becomes aware, including any opposition, nullity, revocation, reexamination whether as a defense in an infringement action brought by PolyBioCept or compulsory license proceedingLion pursuant to Section 6.3.2 or otherwise.
Appears in 2 contracts
Samples: Exclusive License Agreement, License Agreement (Lion Biotechnologies, Inc.)
Patent Invalidity Claim. (a) Each of the Parties Party shall promptly notify the other in the event of any legal or administrative action by any Third Party against a Joint Licensed Patent Right or an AVEO Joint Patent Right claiming Ficlatuzumab, of which it becomes awareaware challenging the validity or enforceability thereof, including any opposition, post-grant review, inter-partes review, nullity, revocation, reexamination reexamination, third party observations, or compulsory license proceeding.
Appears in 2 contracts
Samples: License Agreement (Cara Therapeutics, Inc.), License Agreement (Cara Therapeutics, Inc.)
Patent Invalidity Claim. (a) Each of During the Parties Term, each Party shall promptly notify the other Party in the event of any legal or administrative action by any Third Party against a Joint Licensed Patent Right or an AVEO Patent Right claiming Ficlatuzumab, of which it such Party becomes aware, including any opposition, nullity, revocation, reexamination or compulsory license proceeding or similar proceeding.
Appears in 2 contracts
Samples: License Agreement (Century Therapeutics, Inc.), License Agreement (Century Therapeutics, Inc.)
Patent Invalidity Claim. (a) Each of the Parties shall promptly notify the other in the event of any legal or administrative action by any Third Party against a Joint Orion Patent Right or an AVEO Recro Patent Right claiming Ficlatuzumab, of which it becomes aware, including any opposition, nullity, revocation, reexamination or compulsory license proceeding.
Appears in 1 contract
